Treating chronic obstructive pulmonary disease (COPD) during early stages may slow the progression of the disease, and allow those who suffer from the illness to live longer and suffer less. New research on a promising anti-inflammatory drug, as well as a study on an already well-known anticholinergic drug, offer renewed hope for those who have been diagnosed with COPD.